Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock
CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.75−0.26 (-8.80%)
Close on Nov 18, 2026Market cap $53.09MP/E –Yield –
Corbus Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Corbus Pharmaceuticals's revenue for the twelve months ending Dec 31, 2022 was $0, down 100.0% year over year. For fiscal 2022 it was $0, down 100.0% from the year before. The highest annual figure on record is $36.14M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | -100.0% |
| FY2021 | Dec 31, 2021 | $881.71K | -77.6% |
| FY2020 | Dec 31, 2020 | $3.94M | -89.1% |
| FY2019 | Dec 31, 2019 | $36.14M | +649.5% |
| FY2018 | Dec 31, 2018 | $4.82M | +97.6% |
| FY2017 | Dec 31, 2017 | $2.44M | +27.7% |
| FY2016 | Dec 31, 2016 | $1.91M | +194.8% |
| FY2015 | Dec 31, 2015 | $648.38K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $0 | -100.0% |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $97.32K | -92.1% |
| Q2 FY2021 | Jun 30, 2021 | $136.56K | -52.3% |
| Q1 FY2021 | Mar 31, 2021 | $647.82K | -63.2% |
| Q4 FY2020 | Dec 31, 2020 | $658.20K | -74.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.23M | -52.5% |
| Q2 FY2020 | Jun 30, 2020 | $286.35K | -99.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.76M | -6.6% |
| Q4 FY2019 | Dec 31, 2019 | $2.57M | +33.5% |
| Q3 FY2019 | Sep 30, 2019 | $2.59M | +137.4% |
| Q2 FY2019 | Jun 30, 2019 | $29.09M | +3308.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.89M | +98.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.93M | – |
| Q3 FY2018 | Sep 30, 2018 | $1.09M | +37.0% |
| Q2 FY2018 | Jun 30, 2018 | $853.65K | +143.8% |
| Q1 FY2018 | Mar 31, 2018 | $950.44K | -26.5% |
| Q4 FY2017 | Dec 31, 2017 | $0 | -100.0% |
| Q3 FY2017 | Sep 30, 2017 | $796.31K | +7.2% |
| Q2 FY2017 | Jun 30, 2017 | $350.19K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.29M | – |
| Q4 FY2016 | Dec 31, 2016 | $375.67K | – |
| Q3 FY2016 | Sep 30, 2016 | $742.56K | – |
See a number that looks wrong?